This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleig, U N
Right arrow Articles by Nurse, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleig, U N
Right arrow Articles by Nurse, P

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 May; 12(5): 2295-2301

A dominant negative allele of p34cdc2 shows altered phosphoamino acid content and sequesters p56cdc13 cyclin.

U N Fleig, K L Gould and P Nurse

Department of Biochemistry, University of Oxford, United Kingdom.

ABSTRACT

The cdc2 gene product, a 34-kDa phosphoprotein with serine/threonine protein kinase activity, has been implicated as the key component in the regulation of the eucaryotic cell cycle. Activation of the cdc2 protein kinase is regulated by its phosphorylation state and by interaction with other proteins. We have mutagenized the fission yeast cdc2 gene to obtain conditionally dominant negative alleles. One of these mutants, named DL2, is characterized in this report. Overexpression of the mutant protein in a wild-type cdc2 background is lethal and leads to arrest in the G2 phase of the cell cycle. The mutant phenotype is the result of a single amino acid change in the GDSEID motif of the protein, a region of identity in all cdc2 homologs, and results in a nonfunctional protein that shows an altered content of phosphothreonine. Multicopy suppressors of the dominant negative phenotype have been isolated, and one of these has been shown to encode the cdc13 cyclin B gene product.


Mol Cell Biol. 1992 May; 12(5): 2295-2301




This article has been cited by other articles:

  • Niv, M. Y., Rubin, H., Cohen, J., Tsirulnikov, L., Licht, T., Peretzman-Shemer, A., Cna'an, E., Tartakovsky, A., Stein, I., Albeck, S., Weinstein, I., Goldenberg-Furmanov, M., Tobi, D., Cohen, E., Laster, M., Ben-Sasson, S. A., Reuveni, H. (2004). Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification. J. Biol. Chem. 279: 1242-1255 [Abstract] [Full Text]  
  • Labib, K, Moreno, S, Nurse, P (1995). Interaction of cdc2 and rum1 regulates Start and S-phase in fission yeast. J. Cell Sci. 108: 3285-3294 [Abstract]  
  • Chevalier, S, Tassan, J., Cox, R, Philippe, M, Ford, C (1995). Both cdc2 and cdk2 promote S phase initiation in Xenopus egg extracts. J. Cell Sci. 108: 1831-1841 [Abstract]  
  • Paris, J, Leplatois, P, Nurse, P (1994). Study of the higher eukaryotic gene function CDK2 using fission yeast. J. Cell Sci. 107: 615-623 [Abstract]